Advicenne S.A. (EPA:ALDVI)
France · Delayed Price · Currency is EUR 0.6850
+0.0150 (2.24%)
Oct 2, 2026, 5:35 PM CET
Advicenne Revenue
Advicenne had revenue of 3.70M EUR in the half year ending June 30, 2026, with 40.11% growth. This brings the company's revenue in the last twelve months to 4.43M, up 548.97% year-over-year. In the year 2025, Advicenne had annual revenue of 7.11M with 24.16% growth.
Revenue (ttm)
4.43M
Revenue Growth
+548.97%
P/S Ratio
1.53
Revenue / Employee
591.00K
Employees
11
Market Cap
9.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.11M | 1.38M | 24.16% |
| Dec 31, 2024 | 5.73M | 2.24M | 64.37% |
| Dec 31, 2023 | 3.48M | 475.00K | 15.79% |
| Dec 31, 2022 | 3.01M | -759.00K | -20.15% |
| Dec 31, 2021 | 3.77M | 202.00K | 5.67% |
| Dec 31, 2020 | 3.57M | 981.00K | 37.96% |
| Dec 31, 2019 | 2.58M | -4.34M | -62.68% |
| Dec 31, 2018 | 6.92M | 4.35M | 169.21% |
| Dec 31, 2017 | 2.57M | 679.00K | 35.87% |
| Dec 31, 2016 | 1.89M | 1.08M | 132.27% |
| Dec 31, 2015 | 815.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| genOway Société anonyme | 26.03M |
| Poxel | 7.66M |
| MaaT Pharma | 3.18M |
| Aelis Farma | 2.19M |
| Oncodesign Precision Medicine Société anonyme | 1.81M |
| Aton | 661.00K |
| TME Pharma | 27.00K |
| NFL Biosciences | 188.00 |